September 26, 2024
The 2024 Lancet Series on antimicrobial resistance (AMR) proposes achievable global targets to ensure sustainable access to effective antibiotics.
By 2030, relative to 2019, aim for:
- 10 percent reduction in mortality from AMR.
- 20 percent reduction in inappropriate antibiotic use in humans.
- 30 percent reduction in inappropriate antibiotic use in animals.
Reference: The Lancet Series on Antimicrobial Resistance, 2024